Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000201922

Medchemexpress LLC N-Me-L-Ala-maytansinol | 77668-69-0 | 99.9% | 650.16 g/mol | C32H44ClN3O9 | 1 ML
SDP

Catalog No. 5000201922
Encompass_Preferred

N-Me-L-Ala-maytansinol is a hydrophobic, cell-permeable maytansinoid payload used as a cytotoxic warhead for constructing antibody-drug conjugates (ADCs) in research applications. It is supplied as a DMSO solution and as solid material, and is provided with analytical purity data.

  • Hydrophobic, cell-permeable maytansinoid payload suitable for ADC synthesis.
  • Available as 10 mM in DMSO (1 mL) solution and as solid in 5 mg-500 mg sizes.
  • High purity (99.9% by analysis).
  • Molecular weight 650.16 g/mol; formula C32H44ClN3O9.
  • CAS number 77668-69-0; intended for research use only.

Catalog No. 50-002-01922 Supplier Medchemexpress LLC Supplier No. HY12666310MM 1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

N-Me-L-Ala-maytansinol is a hydrophobic, cell-permeable maytansinoid payload used as a cytotoxic warhead for constructing antibody-drug conjugates (ADCs) in research applications. It is supplied as a DMSO solution and as solid material, and is provided with analytical purity data.

  • Hydrophobic, cell-permeable maytansinoid payload suitable for ADC synthesis.
  • Available as 10 mM in DMSO (1 mL) solution and as solid in 5 mg-500 mg sizes.
  • High purity (99.9% by analysis).
  • Molecular weight 650.16 g/mol; formula C32H44ClN3O9.
  • CAS number 77668-69-0; intended for research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.